The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects.
Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The overall objective for this study is to test whether β2-agonists will affect the
cardiopulmonary capacity of VSD-operated patients compared with un-operated VSD-patients and
healthy age- and gender-matched controls.